RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:QuestionPilotboy246 wrote: pointer wrote: Freddy6980 wrote: If Paul amd the company was interested in the TSX route it would have already happened. They hired the MM to go to Nasdaq they added the board member to go to Nasdaq they need a few more items to be eligible to be checked before the apply but if you listen to Paul he wants that U.S.A. money/exposure all of the above and if Biocloud is the game changer that most if us here think it is then it only makes sense to go straight to Nasdaq because TSX still equals OTC on the US side until they go to Nasdaq and what does that accomplish. I could be wrong but that is my reasoning. GLTA and God Bless!
You are wrong. And equating the TSX to OTC is just arrogant american bs.
Yet another one-stock fool.
Because he has an opinion he is a fool?
Seems to be odd logic.
If someone considers Freddy a fool it's because he posts foolish things. Example: trying to characterize as fact his bogus claim that KNR will not uplist to TSX. KNR has said itself it will uplist to TSX.
From KNR's Dec. 16, 2020 NR:
Uplisting to TSX, NASDAQ
The Company's board of directors has authorized management to review the process to graduate the Company from the CSE to the TSX. If the Company is successful in uplisting to the TSX, Kontrol intends to, as soon as practical, begin the process of filing a Form F-1 Registration Statement with the Securities and Exchange Commission of the United States (the "SEC"), which will enable Kontrol to apply to be listed on the NASDAQ.
Completion of any uplisting is subject to meeting certain conditions, as well as the approval of the TSX. There is no assurance that the TSX will approve the listing application or that Kontrol will complete the uplisting as contemplated. There is no assurance that either the SEC or NASDAQ will approve the Company's respective applications or that Kontrol will complete the listing to the NASDAQ as proposed.
TL;DR: Freddy doesn't know what he's talking about.